Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic testing for BRCA1 and BRCA2 in the Province of Ontario.

Clinical genetics - 1 Mar 2016

Finch A, Wang M, Fine A, Atri L, Khalouei S, Pupavac M, Rosen B, Eisen A, Elser C, Charames G, Metcalfe K, Chang M C, Narod S A, Lerner-Ellis J

Abstract excerpt

In 2001, genetic testing for BRCA1 and BRCA2 was introduced in Ontario, for women at high-risk of breast or ovarian cancer. To date over 30,000 individuals have been tested throughout Ontario. Testing was offered to all Ontario residents who were eligible under any of 13 criteria. We report the results of tests conducted at Mount Sinai Hospital from 2007 to 2014. A total of 4726 individuals were tested, 764...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Mutation

Share to Ontario

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 26219728
DOI: 10.1111/cge.12647

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic testing for BRCA1 and BRCA2 in the Province of Ontario.PMID 26219728Read ↗

Development of a comprehensive approach to adult hereditary cancer testing in Ontario.Semantic proximity Read ↗

Real-world health services utilisation and outcomes after BRCA1 and BRCA2 testing in Ontario, Canada: the What Comes Next Cohort Study protocol.Semantic proximity Read ↗

Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.Semantic proximity Read ↗

Uptake of clinical genetic testing for ovarian cancer in Ontario: a population-based study.Semantic proximity Read ↗

Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing.Semantic proximity Read ↗

Breast and Ovarian Cancer Among Individuals Undergoing BRCA1 and BRCA2 Testing.Semantic proximity Read ↗

Multigene panel testing for hereditary breast and ovarian cancer in the province of OntarioSemantic proximity Read ↗

Development of the Ontario Hereditary Cancer Research Network, a unified registry as a resource for individuals with inherited cancer syndromes: an observational registry creation protocol.Semantic proximity Read ↗

Building the What Comes Next Cohort for BRCA1 and BRCA2 testing: a descriptive analysis.Semantic proximity Read ↗

Founder BRCA1/BRCA2/PALB2 pathogenic variants in French-Canadian breast cancer cases and controls.Semantic proximity Read ↗

Recognizing BRCA gene mutation risk subsequent to breast cancer diagnosis in southwestern Ontario.Semantic proximity Read ↗

Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.